The company is commercializing its FDA-cleared bio-ConneKt® Wound Matrix to the advance wound care market.
The company is commercializing its FDA-cleared bio-ConneKt® Wound Matrix to the advance wound care market.
ALACHUA, Fla.--(BUSINESS WIRE)-- UF Innovate | Sid Martin Biotech, the leading biotechnology incubator at the University of Florida, is pleased to announce that resident company MLM Biologics, Inc. has graduated from its program. MLM Biologics is a medical device company that provides evidence-based solutions in the advance wound care and musculoskeletal clinical spaces. The company designs, develops, manufactures and commercializes clinical products that are aimed to offer the best medical-economic alternatives in those markets. The company is currently commercializing its flagship product, the FDA-cleared, bio-ConneKt® Wound Matrix, in the advance wound care market. Having successfully obtained requisite clearances for use across civilian, military and VA clinical spaces, MLM will be graduating into a stand-alone commercial space in Gainesville’s Innovation District to expand their manufacturing capabilities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190528005269/en/
“Retaining a high growth company like MLM Biologics in Alachua County and in the State is a big win for our economy. MLM Biologics will continue to expand their operations and bring investments and jobs into our community,” said Merrie Shaw, Assistant Director of UF Innovate | Sid Martin Biotech. The company was able to locate their headquarters locally due to the availability of suitable, specialized commercial space, which is not readily available in many other communities.
MLM Biologics joins more than 60 biotech company alumni of Sid Martin Biotech, including AxoGen (NASDAQ: AXGN), Applied Genetic Technologies Corporation (NASDAQ: AGTC), RTI Surgical (NASDAQ: RTIX), Ology Bioservices and Captozyme.
“As a start-up, we faced an unexpected, abrupt change in our business plan. Sid Martin Biotech provided a soft landing and the platform for us to mature as a commercial entity. With the core of MLM fueled locally, we are especially pleased to continue our growth and expansion here,” said Chandra Nataraj, CEO & Co-Founder of MLM Biologics.
Mark Long, Director of UF Incubation Services, stated, “This is a great example of UF Innovate’s role in economic development in Gainesville – we support startup companies so they can graduate and occupy space locally, adding jobs and revenues to the local and state economy.”
About MLM Biologics
MLM Biologics is a Florida-based startup company focused on delivering clinically and cost-effective medical solutions to serve the needs of patients worldwide. The company has developed a proprietary platform technology that enables design and manufacture of clinically useful biologic products across a wide range of medical specialties. MLM Biologics, an ISO-13485 compliant company, is currently commercializing the bio-ConneKt® Wound Matrix, an FDA-cleared medical device for clinically managing a variety of chronic, acute, traumatic and burn wounds. The bio-ConneKt® Wound Matrix is helping change wound care management from the traditional “low tech, high touch” approach to a “high tech, low touch” paradigm that benefits all stakeholders in the wound care space. For more information, visit MLM Biologics.
About UF Innovate | Sid Martin Biotech
UF Innovate | Sid Martin Biotech is the leading biotechnology incubator headquartered at the University of Florida in Alachua, Florida, at Progress Park. Sid Martin has been honored with national and international awards for incubator excellence and achievements in technology commercialization, funding access, job creation and technology-based economic development. It is dedicated to mentoring and accelerating the growth of innovative early-stage bioscience and biotechnology companies and supporting the economic growth of the North Central Florida region. For more information, visit Sid Martin Biotech.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190528005269/en/
Contacts
Company Contact:
MLM Biologics, Inc.
Chandra Nataraj, PhD, DVM
CEO & CTO
cnataraj@mlmbiologics.com
http://mlmbiologics.com/
Sid Martin Biotech Contact:
UF Innovate | Sid Martin Biotech
Merrie Shaw
Assistant Director
mashaw@ufl.edu
http://innovate.research.ufl.edu/sid-martin-biotech/
Source: UF Innovate | Sid Martin Biotech